MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN

(2012) Boning Liu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1

(2012) Rui Wang et al.   PLoS One

MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R

(2012) Biyun Wang et al.   PLoS One

Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer

(2012) Yu Sun et al.   PLoS One

Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1

(2011) Yi-Kun Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2

(2011) J. Lu et al.   CANCER RESEARCH

Development of microRNA-145 for therapeutic application in breast cancer

(2011) Seok-Jun Kim et al.   JOURNAL OF CONTROLLED RELEASE

A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)

(2011) Konstantinos J Mavrakis et al.   NATURE GENETICS

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

(2011) A Holleman et al.   ONCOGENE

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening

(2010) R. A. Smith et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death

(2010) L. Galluzzi et al.   CANCER RESEARCH

Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer

(2010) B. Zhang et al.   CARCINOGENESIS

Repressing the repressor: A new mode of MYC action in lymphomagenesis

(2010) Sandrine Sander et al.   CELL CYCLE

Targeting microRNAs in cancer: rationale, strategies and challenges

(2010) Ramiro Garzon et al.   NATURE REVIEWS DRUG DISCOVERY

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

(2010) Keitaro Kojima et al.   PROSTATE

MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer

(2009) Melissa Crawford et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

(2009) Y. Li et al.   CANCER RESEARCH

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

(2009) J. T. Huse et al.   GENES & DEVELOPMENT

MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer

(2009) Junfang Ji et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA-26a Targets the Histone MethyltransferaseEnhancer of Zeste homolog 2during Myogenesis

(2008) Chung Fai Wong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Endogenous human microRNAs that suppress breast cancer metastasis

(2008) Sohail F. Tavazoie et al.   NATURE

The BCL-2 protein family: opposing activities that mediate cell death

(2007) Richard J. Youle et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY